2019-05-13

LANXESS at China International Animal Husbandry Expo (CAHE) 2019, WuHan International Expo Centre, China, stand AL05, Hall A3, May 18-20, 2019

Effective biosecurity barrier controls essential for the prevention and control of African Swine Fever (ASF) and Avian Influenza (AI)

Shanghai – May 13, 2019 – with two of the most feared epidemic diseases, African Swine Fever (ASF) and Avian Influenza (AI) spreading rapidly across China and Southeast Asia, specialty chemicals company, LANXESS, have emphasized the key role biosecurity barrier controls must play in helping to control their spread. “Disease prevention and control must always be the prime focus,” said Stephan Cho, Head of Market Segment Disinfection in the Material Protection Products business unit (MPP), at LANXESS.  “Instead of waiting for a disease challenge to happen, producers must take steps to build robust protocols that prioritize hygiene.  Biosecurity barrier controls, utilizing proven effective biocides, are the greatest weapons swine and poultry producers have in helping to prevent the spread and introduction of ASF and AI.”


Cho’s comments come ahead of LANXESS’ attendance at the annual China International Animal Husbandry Expo (CAHE), WuHan International Expo Centre, the central meeting point for veterinarians, influencers, officials and livestock producers in China.


“Implementing strict biosecurity barrier controls is the only real way of stopping the spread of ASF and AI from one production facility to another,” said Cho. “Humans, vehicles, wild animals and birds are all proven vectors through which these diseases rapidly spread.  Therefore, producers need to achieve the highest possible levels of biosecurity, leveraged by good buy-in and compliance from management, their staff and their suppliers”.


As part of their commitment to providing advice and support, LANXESS will highlight the key elements of an effective 360o approach to biosecurity best practice for surfaces, equipment and farm site perimeters, on their booth at CAHE 2019.

Virkon S and Virkon LSP proven effective against ASF and AI

LANXESS offers producers the proven broad spectrum virucidal disinfectants Virkon S and Virkon LSP for ASF and AI biosecurity prevention and control measures. Both Virkon disinfectants have been independently tested for virucidal efficacy against ASF and AI and have been proven to be effective against the viruses in the presence of organic challenge and at low temperatures, reflecting their proven performance and suitability for real world “on-farm” conditions. In addition, LANXESS is offering swine and poultry producers timely advice on the clinical symptoms of ASF and AI, and guidance on implementing enhanced biosecurity protocols across the range of possible infection vectors, including transport vehicles, housing facilities, personnel, wild animals and birds.

Virkon – the science to kill pathogens

“Virkon biocidal solutions have been scientifically formulated to address the major disease concerns facing modern livestock production.  Their science-backed formulations offer livestock producers disinfectant products with performance characteristics that have defined biosecurity standards for over 30 years, making them the disinfectants of choice to help prevent and control the spread of epidemic diseases such as ASF and AI,” adds Cho.


Visit LANXESS at CAHE 2019 (18-20 May) on stand AL05 in Hall A3 for further information and advice.
Read more about LANXESS and their commitment to biosecurity at www.virkon.com

 

About LANXESS

LANXESS is a leading specialty chemicals company with sales of EUR 7.2 billion in 2018. The company currently has about 15,400 employees in 33 countries and is represented at 60 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

 

LANXESS China

On January 31, 2005, the company was initially listed on the Frankfurt Stock Exchange and LANXESS Chemical (China) Co., Ltd. officially started operations. LANXESS has 15 subsidiaries, 7 R&D centers and 7 production sites with around 1,500 employees in Greater China. LANXESS works closely with its local partners to develop market-oriented solutions that meet local market needs.

 

Forward-Looking Statements

This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

Information for editors:

All LANXESS news releases and accompanying photo, video and audio materials can be found at http://www.lanxess.cn, http://www.weibo.com/lanxess, or LANXESS’ official WeChat account: LANXESS_china

 

 

Contact

Yu Fiona

Yu Fiona
Corporate Communications

Phone: +86 21 6109 6666

Fax: +86 21 6109 6717

send E-Mail

  • Gallery